不同类型肿瘤中IFITM1研究进展

承德医学院学报 ›› 2022, Vol. 39 ›› Issue (5): 424-427.

不同类型肿瘤中IFITM1研究进展

田朵朵¹, 邓程¹, 赵学荣¹, 王建平¹, 肖丽君^1,*, 丁实²

1.承德医学院免疫学教研室,河北承德 067000;
2.承德医学院药理学教研室

收稿日期:2021-10-12 出版日期:2022-10-10 发布日期:2022-10-24
通讯作者: *
基金资助:
河北省教育厅课题（ZD20180004,QN2016017,QN2020208）; 河北省医学科学研究课题（20160009,20211467,20210691）; 承德医学院校级课题 (202014,201806)

Received:2021-10-12 Online:2022-10-10 Published:2022-10-24

摘要/Abstract

中图分类号:

R730

田朵朵, 邓程, 赵学荣, 王建平, 肖丽君, 丁实. 不同类型肿瘤中IFITM1研究进展[J]. 承德医学院学报, 2022, 39(5): 424-427.

[1] Liang RB, Li XX, Zhu XD, et al.Deciphering the Roles of IFITM1 in Tumors[J]. Molecular Diagnosis & Therapy, 2020, 24(4): 433-441.
[2] Lui AJ, Geanes ES, Ogony J, et al.IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21[J]. Cancer Letters, 2017, 399: 29-43.
[3] He J, Li J, Feng W, et al.Prognostic significance of INF-induced transmembrane protein 1 in colorectal cancer[J]. International Journal of Clinical and Experimental Pathology, 2015, 8(12): 16007-16013.
[4] Zhang L, Wang Z, Kong D, et al.Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells[J]. Bioscience Biotechnology and Biochemistry, 2020, 84(8): 1603-1613.
[5] Yu F, Xie D, Ng SS, et al.IFITM1 promotes the metastasis of human colorectal cancer via CAV-1[J]. Cancer Letters, 2015, 368(1): 135-143.
[6] Popson SA, Ziegler ME, Chen X, et al.Interferon-induced transmembrane protein 1 regulates endothelial lumen formation during angiogenesis[J]. Arteriosclerosis Thromb Vasc Biol, 2014, 34(5): 1011-1019.
[7] Kim BS, Yang SS, Kim CS, et al . Zoledronate suppresses VEGF-induced capillary tube formation and inhibits expression of interferon-induced transmembrane protein-1 in human umbilical vein endothelial cells[J]. Int J Mol Med,2018,41(5): 2879-2884.
[8] Koh YW, Han JH, Jeong D, et al.Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma[J]. Pathol Res Pract,2019,215(7): 152444.
[9] Borg D, Hedner C, Gaber A, et al.Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma[J]. Biomarker Research, 2016, 4:10.
[10] Lee J, Goh SH, Song N, et al.Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism[J]. Am J Pathol,2012,181(1): 43-52.
[11] 刘宇虎,柳娟,郭健,等. 干扰素诱导的跨膜蛋白-1对诊断结直肠癌的临床价值[J]. 南方医科大学学报,2008,(11):1950-1953.
[12] Sari IN, Yang YG, Phi LT, et al.Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer[J]. Oncotarget,2016,7(52): 86039-86050.
[13] He JD, Luo HL, Li J, et al.Influences of the interferon induced transmembrane protein 1 on the proliferation, invasion, and metastasis of the colorectal cancer SW480 cell lines[J]. Chinese Medical Journal, 2012, 125(3): 517-522.
[14] Yang J, Li L, Xi Y, et al.Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer[J]. Cancer Sci,2018,109(10): 3115-3128.
[15] 陈建军. DDR2和IFITM1在非小细胞肺癌中的表达及临床意义[J]. 现代肿瘤医学,2020,28(10):1677-1681.
[16] Yan J, Jiang Y, Lu J, et al.Inhibiting of Proliferation, Migration, and Invasion in Lung Cancer Induced by Silencing Interferon-Induced Transmembrane Protein 1 (IFITM1)[J]. Biomed Res Int,2019,2019: 9085435.
[17] 苏日格,曹小莹. DDR2和IFITM1在鼻咽癌中的表达及临床意义[J]. 中国医师杂志,2019,21(11):1667-1671.
[18] 杨蓉,张潍,王建,等. siRNA沉默IFITM1对卵巢癌细胞系CP70生物学效应的影响及机制研究[J]. 现代肿瘤医学,2019,27(13):2231-2235.
[19] Kim NH, Sung HY, Choi EN, et al.Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer[J]. Oncol Rep, 2014,31(5): 2139-2146.
[20] Zheng W, Zhao Z, Yi X, et al.Down-regulation of IFITM1 and its growth inhibitory role in cervical squamous cell carcinoma[J]. Cancer Cell Int,2017,17: 88.
[21] Akyerli CB, Beksac M, Holko M, et al.Expression of IFITM1 in chronic myeloid leukemia patients[J]. Leuk Res,2005,29(3): 283-286.
[22] Yu F, Ng SS, Chow BK, et al.Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cells[J]. J Neurooncol,2011,103(2): 187-195.

不同类型肿瘤中IFITM1研究进展

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	龚莉焰, 李双阳, 杨思进, 白雪. 蛭龙活血通瘀胶囊治疗动脉粥样硬化的作用机制[J]. 承德医学院学报, 2022, 39(5): 371-375.
[2]	付宜拥, 闫海良, 高龙潭. 益气散结汤对Ⅲ/Ⅳ期食管癌患者疾病控制率及血清相关细胞因子水平的影响[J]. 承德医学院学报, 2022, 39(5): 397-400.
[3]	于金正, 赵润泽, 魏宇辰, 柳佳欣, 李晓菊, 张存. 外泌体在乳腺癌发生发展中的作用[J]. 承德医学院学报, 2021, 38(6): 513-517.
[4]	于静, 吴晓光. 自噬与炎症反应对缺血性脑卒中影响的研究进展[J]. 承德医学院学报, 2021, 38(3): 239-242.
[5]	李哲宏, 吕家兴, 甘新天, 白磊鹏, 曹海营, 金宇. 兔VX2骨肿瘤微环境中IL-4和CD34表达关系[J]. 承德医学院学报, 2021, 38(3): 187-190.
[6]	蒋勇军, 张辉泽, 邝春洁, 刘佳芬, 陈婷. 经尿道行微创钬激光膀胱肿瘤切除术治疗浅表膀胱肿瘤的应用[J]. 承德医学院学报, 2021, 38(2): 103-105.
[7]	李美辰, 潘靖丹, 吴合亮, 张晶晶, 徐雯雯, 杜娈英. 旋毛虫抗原成分抗肿瘤作用的研究进展[J]. 承德医学院学报, 2021, 38(1): 53-56.
[8]	关健华, 张俊琳, 谭银欢, 李伟文, 林启谋. 江门五邑地区乳腺良性肿瘤日间切除的应用研究[J]. 承德医学院学报, 2020, 37(6): 465-468.
[9]	马慧, 郭信伟, 叶宏勋. 胸下段食管癌术后预防照射范围的临床研究[J]. 承德医学院学报, 2020, 37(6): 475-478.
[10]	田庄, 李晓菊, 罗嘉嘉, 黄平, 郭虎, 高源. 肿瘤相关成纤维细胞在乳腺癌发生发展及耐药中的作用[J]. 承德医学院学报, 2020, 37(5): 410-414.
[11]	陈成. 糖皮质激素及其受体在神经系统疾病中的作用及机制研究进展[J]. 承德医学院学报, 2020, 37(5): 415-418.
[12]	朱宗鑫, 乔婷婷, 钟亮亮, 姚家祥, 吴志浩. NKX2-1在肺癌中的研究进展[J]. 承德医学院学报, 2020, 37(5): 423-427.
[13]	陈文丽, 庞桂芬, 杨林瀛, 姜锋, 赵志伟, 郑洪飞. 大气道恶性肿瘤103例临床分析[J]. 承德医学院学报, 2020, 37(5): 430-431.
[14]	夏丽娟, 唐旭, 苏平. 热塑体膜固定技术对胸腹部肿瘤放疗患者摆位误差及固定精确度的影响[J]. 承德医学院学报, 2020, 37(4): 330-332.
[15]	屠刚亮, 宋金起, 周亚男, 许长理, 徐辉. 膀胱异位前列腺1例[J]. 承德医学院学报, 2020, 37(3): 254-255.